MENU
+Compare
NUMIF
Stock ticker: OTC
AS OF
May 22 closing price
Price
$0.03
Change
+$0.01 (+50.00%)
Capitalization
44.18M

NUMIF Numinus Wellness Inc. Forecast, Technical & Fundamental Analysis

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes... Show more

NUMIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUMIF with price predictions
May 22, 2025

NUMIF's Stochastic Oscillator remains in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 22, 2025. You may want to consider a long position or call options on NUMIF as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUMIF just turned positive on May 22, 2025. Looking at past instances where NUMIF's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

NUMIF moved above its 50-day moving average on May 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NUMIF crossed bullishly above the 50-day moving average on May 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where NUMIF advanced for three days, in of 190 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUMIF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUMIF broke above its upper Bollinger Band on May 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.512) is normal, around the industry mean (4.650). P/E Ratio (0.000) is within average values for comparable stocks, (71.885). NUMIF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). NUMIF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (2.581) is also within normal values, averaging (9.268).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NUMIF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUMIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
NUMIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUMIF is expected to report earnings to fall 50.00% to 0 cents per share on November 29

Numinus Wellness Inc. NUMIF Stock Earnings Reports
Q3'24
Est.
$-0.01
Q2'24
Est.
$-0.01
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.01
Q3'23
Missed
by $0.01
The last earnings report on July 11 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 31.22K shares outstanding, the current market capitalization sits at 44.18M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
801 - 33 Water Street
Phone
+1 604 649-3229
Employees
30
Web
https://www.numinus.ca
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQIX866.507.36
+0.86%
Equinix
PRT3.890.03
+0.78%
PermRock Royalty Trust Trust
CHCO119.55N/A
N/A
City Holding Company
UGP2.97N/A
N/A
Ultrapar Participacoes SA
CKPT4.18N/A
N/A
Checkpoint Therapeutics

NUMIF and Stocks

Correlation & Price change

A.I.dvisor tells us that NUMIF and PHCI have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUMIF and PHCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUMIF
1D Price
Change %
NUMIF100%
+26.24%
PHCI - NUMIF
11%
Poorly correlated
N/A
PIII - NUMIF
9%
Poorly correlated
N/A
DCGO - NUMIF
8%
Poorly correlated
N/A
BDULF - NUMIF
7%
Poorly correlated
N/A
AIRS - NUMIF
6%
Poorly correlated
N/A
More